WARF | GenomeWeb

WARF

NEW YORK (GenomeWeb News) – Public interest groups Consumer Watchdog and the Public Patent Foundation said Tuesday that they have asked a federal appeals court to invalidate a patent held by the Wisconsin Alumni Research Foundation covering human embryonic stem cells.

Sysmex of Hyogo, Japan, has received US Patent No. 8,187,809, "Method for judging lymph node metastasis of stomach cancer and kit used therefor." A marker is provided that is capable of diagnosing the lymph node metastasis of stomach cancer.

University College Dublin of Dublin, Ireland, has received US Patent No. 8,116,551, "Method and system for image analysis." A method for determining the level of expression of objects of interest using an automated image analysis system is claimed.

IP Roundup

Premium

Canon of Tokyo has received US Patent No. 8,025,853, "Biochemical processing apparatus." The apparatus includes a stage for receiving a biochemical reaction cartridge.

IP Roundup

Premium

Chung Hua University of Hsinchu, Taiwan, has received US Patent No.

IP Roundup

Premium

Canon of Tokyo has received US Patent No.

The Wisconsin Institute for Discovery houses one University-led center and a private institute in Madison.

IP Roundup

Premium

University of Maryland, Hologic, GenMark Diagnostics, Wisconsin Alumni Research Foundation, Fluidigm, Affymetrix, Jackson Laboratory, Agilent Technologies

IP Roundup

Premium

Wisconsin Alumni Research Foundation, MDS Analytical Technologies, Aviva Biosciences

People in the News

Klaus Lindpainter is the new VP of R&D and CSO at Strategic Diagnostics; Intrexon appoints Thomas Goralski as senior VP; WARF loses director of licensing Craig Christianson, and more.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.